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after the surgical wound was treated with
a small quantity of betadine® the patient
presented with grade 4 anaphylactic
shock with acute respiratory distress
syndrome requiring intensive resuscita-
tion for 24 h. Sampling performed
immediately after the incident showed the
tryptase level to be 39 llg/I and serum
histamine level 22.4 nmol/1.
Personal history included a previous
surgery for peripheral neurolysis in 2000,
during which acute urticaria of the left
arm spreading to the neck and face was
observed 20 min after swabbing with
betadine®.
Skin tests carried out 9 months after
the anaphylactic shock on skin reactive to
codeine (4 mm) were negative for all
curarizing agents. Prick test to betadine®
was positive: 5 mm, intradermal test
(IDT) was positive at 10-4 (10 llg/ml);
7.5 mm (injection papula 3 mm), prick
test to povidone; 3 mm, IDT to povidone
was positive at 10-4; 7 mm (injection
papula: 2.5 mm).
Total IgE value was 5000 kIV/1. The
results of the leukocyte histamine release
test could not be interpreted because
cellular histamine was lower than normal
(280 nmol instead of 600). Also, the
iodinated povidone interfered with the
histamine assay. The basophil activa-
tion test (BAT) was positive to betadine®
(14 % CD3 +, CD63 + and to povidone:
18% for a negative control at 0.5%
and a positive anti-IgE control at
23%). The leukotriene release test was
positive to betadine® and to povidone:
180 and 140 pg/ml (normal limit
:S 100 pg/ml). Both tests were negative to
atracurium.
The radioimmunoassay (RIA) to qua-
ternary ammonium ions was positive at
4.8% but the inhibition test with atracu-
rium was negative. RIA to penthotal was
positive. Serum tryptase values were
normal, thus eliminating the acceptable
clinical explanation that the severity
of the shock may be related to latent
mastocytosis.
Anaphylaxis induced by iodinated
povidone is anaphylaxis to povidone, the
carrier molecule for iodine atoms. Ana-
phylaxis is documented by positive skin
tests, BAT and cysteinyl-Ieukotriene
release test (CAST), (I, 2). Positive RIA
to quaternary ammonium ions is of no
value: there is no RIA inhibition with
atracurium and the skin tests to curares
are negative. Only 89% specificity has
been documented (3-5). Similarly, RIA
to penthotal may produce false positive
results (6).
Povidone was previously used via the
IV route as a plasma replacement or as
a solubilizing agent for injectables.
Doxycycline IV that contained povidone
was withdrawn from the Pharmacopoeia
because of anaphylactic reactions. Iodi-
nated povidone is a skin antiseptic but
the case reported here shows the risk of
intra-vascular passage if a little quantity
is introduced in a surgical wound.
When the patient was questioned later,
it was found that he had had a less
serious reaction earlier. This is the
second case of allergy reported to
povidone (7).
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Local anesthetics (LA) are widely used
drugs in dentistry and ambulatory sur-
gery. Adverse reactions to LA are fre-






probably < I %
(I, 2). LA are grouped, depending on
their chemical structure, into two categ-
ories: benzoate esters and amides; the
latter group is usually well tolerated.
In some exceptional reports of allergic
reactions caused by LA of the amide
group, mainly to lidocaine, other amide
drugs, such as mepivacaine and ropiva-
caine, were usually well tolerated (3).
We present a 46-year-old woman,
referred to us for evaluation of tolerance
to LA before the performance of deep
skin biopsies and dental procedures; in




brief, she had anaphylactic reactions after
the administration of an unknown local
anesthetic agent 20 years ago and after
lidocaine administration 12 years ago.
Five years ago the patient also reported a
large local urticaria after topical use of
lidocaine (EMLA® anesthetic disc,
AstraZeneca, USA). After obtaining the
patient's consent, the diagnostic
approach was carried out. Skin tests were
performed with commercial LA drugs.
Positive skin-prick test results with full-
strength drug were obtained for lidocaine
(AstraZeneca) with a wheal diameter of
5 x 4 mm, bupivacaine (AstraZeneca)
with 6 x 4 mm and mepivacaine (Labo-
ratorios lnibsa, Portugal) with 4 x 3 mm.
Skin-prick test for ropivacaine
(AstraZeneca) was negative, but the
intradermal (TD) test with I : 100 dilution
was positive (12 x 10 mm). Then, we
performed skin tests (prick and TD test-
ing) with procaine (Labesfal, Portugal),
the LA belonging to the ester group,
which were negative. On the next day, the
patient was admitted to an intensive care
unit for challenge procedures. The
subcutaneous challenge with I ml of
procaine (2%) was negative, (three
biopsies ~ forearm and thigh), with no
adverse reactions. In order to ensure that
the positive skin test results were relevant,
we carried out placebo controlled (saline),
single-blind subcutaneous challenge test
with 0.1 ml of ropivacaine (0.2%, pre-
servative-free solution), and it was
strongly positive (severe systemic reaction
with laryngospasm, treated with paren-
teric epinephrine), confirming the diag-
nosis of allergy to LA of the amide group.
The immediate hypersensitivity reaction
was proved in this case and, as far as we
know, this is the first report of severe
hypersensitivity to ropivacaine, a drug
unique among LA because it is prepared
as an isomer (the S-enantiomer of the
propyl homologue of bupivacaine) rather
than a racemic mixture. The therapeutic
alternative was procaine, the ester anes-
thetic, not routinely used nowadays. In
conclusion, although ropivacaine is a
first-choice drug for the majority of LA
allergic patients, cross-reactivity must be
thought within the amide group, in
patients with positive skin tests (4); in
these cases, allergy evaluation must be
accomplished in a reference centre in
order to identify safe alternatives (3).
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Comparison of skin prick test
and atopy patch test with dust
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The atopy patch test (APT) was intro-
duced to assess sensitization to inhalant
allergens in patients with atopic eczema







Skin prick and atopy
patch test in mite
allergy.
sought to evaluate the response to mite
extracts using APT and to skin prick tests
(SPT) in subjects with persistent respir-
atory symptoms, AEDS, and with both
the diseases.
Eighty-nine patients were included in
the study, 75 (84.3%) children and 14
(15.7%) adults, 54 (60.7%) males and 35
(39.3%) females. They were divided in to
three groups of 47, 15, and 27 subjects,
with only respiratory symptoms, only
AEDS, or both, respectively. They
underwent usual SPTs with mite extracts
and APTs by mite extract in Finn
chambers, which were removed after
48 h, with readings after 20 min and 24 h.
Of the 89 patients, 24 showed a posit-
ive SPT and 69 a positive APT; in 17 both
SPT and APT were positive, while 13
were negative to both the tests. The APT
was more frequently positive than SPT
not only in the two groups with
AEDS - 32 of 42 (86.5%) vs eight of 42
(21.6%) - but also in the group with only
respiratory symptoms - 37 of 47 (78.7%)
vs 16 of 47 (34%).
These results confirm the high value of
APT in patients with mite-induced AEDS
and suggest that its routine use might
improve the diagnosis of respiratory
allergy to house dust mites also.
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Contact dermatitis due to a
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Several components of splints, such as
rubber or neoprene, have been implicated
